Management of patients with elevated Self-BAT scores or other bleeding symptoms: Updated overview for primary care practitioners.
Journal
Canadian family physician Medecin de famille canadien
ISSN: 1715-5258
Titre abrégé: Can Fam Physician
Pays: Canada
ID NLM: 0120300
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
entrez:
13
7
2022
pubmed:
14
7
2022
medline:
16
7
2022
Statut:
ppublish
Résumé
To provide recommendations for management of patients presenting with elevated self-administered bleeding assessment tool (Self-BAT) scores or other bleeding symptoms in a primary care setting. Primary research sources, clinical review articles, and interviews with research staff, hematologists, and family physicians were used to create the poster tools and reference guide resources. Recommendations to manage a patient with an elevated Self-BAT score or other bleeding symptoms include reviewing the results of the Self-BAT to clarify relevant symptoms, performing initial diagnostic laboratory tests, and doing basic symptom management. Clinical judgment should be used when determining whether referral to a hematologist is necessary, but referral should be considered if the bleeding score is abnormal or if initial management options are ineffective. Some bleeding symptoms warrant evaluation by a gastroenterologist, obstetrician-gynecologist, or otolaryngologist. Primary care providers should conduct a thorough review of the Self-BAT results and associated management recommendations when working with a patient presenting with an elevated score or other bleeding manifestations. A review consists of the clarification of relevant symptoms, appropriate initial laboratory workups, and patient education. Treatment options for symptom management should be explored while recognizing the threshold for referral to a hematologist.
Identifiants
pubmed: 35831073
pii: 68/7/494
doi: 10.46747/cfp.6807494
pmc: PMC9842138
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
494-499Informations de copyright
Copyright © 2022 the College of Family Physicians of Canada.
Références
J Thromb Haemost. 2012 Nov;10(11):2223-9
pubmed: 22974079
Womens Health (Lond). 2016 Jan;12(1):63-9
pubmed: 26756830
J Womens Health Gend Based Med. 2002 Jan-Feb;11(1):39-44
pubmed: 11860723
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):547-552
pubmed: 33275722
Am J Obstet Gynecol. 2009 Jul;201(1):12.e1-8
pubmed: 19481722
Blood Adv. 2021 Jan 12;5(1):301-325
pubmed: 33570647
Genet Med. 2011 May;13(5):365-76
pubmed: 21289515
J Thromb Haemost. 2008 Dec;6(12):2062-6
pubmed: 18983516
Am J Obstet Gynecol. 2013 Sep;209(3):202.e1-7
pubmed: 23727521
TH Open. 2019 Nov 29;3(4):e350-e355
pubmed: 31799494
Am Fam Physician. 2016 Feb 15;93(4):279-86
pubmed: 26926815
Hematol Oncol Clin North Am. 2012 Apr;26(2):321-44, viii
pubmed: 22463830
Blood Adv. 2021 Jan 12;5(1):280-300
pubmed: 33570651
Haematologica. 2020 Jul;105(7):1969-1976
pubmed: 31624107
Haemophilia. 2017 Jul;23(4):e282-e286
pubmed: 28544019
J Thromb Haemost. 2010 Sep;8(9):2063-5
pubmed: 20626619
Haemophilia. 2000 Nov;6(6):643-8
pubmed: 11122390
Haemophilia. 2004 Mar;10(2):158-61
pubmed: 14962204
Womens Health (Lond). 2016 Jan;12(1):21-6
pubmed: 26693585
BJOG. 2004 Dec;111(12):1425-8
pubmed: 15663130
Am J Hematol. 2020 Sep;95(9):1022-1029
pubmed: 32419248
Acta Obstet Gynecol Scand. 2014 Jan;93(1):52-7
pubmed: 24266506
Semin Thromb Hemost. 2012 Oct;38(7):711-9
pubmed: 22941792
Haemophilia. 2015 Sep;21(5):e384-8
pubmed: 26179127
Haematologica. 2013 May;98(5):667-74
pubmed: 23633542